<?xml version="1.0" encoding="UTF-8"?>
<p id="Par19">Influenza B viruses (IBVs) are one of the main causes of seasonal influenza cases, accounting for up to 40% of total cases [
 <xref ref-type="bibr" rid="CR1">1</xref>]. However, during the 2011/2012 and 2015/2016 influenza seasons in China, 53.7 and 52.2% of influenza notifications were due to IBV infections [
 <xref ref-type="bibr" rid="CR2">2</xref>]. There are two lineages of IBVs currently in circulation; B/Victoria/2/1987-like (Victoria) and B/Yamagata/16/1988-like (Yamagata). Generally, IBVs cause a less severe respiratory disease compared to influenza A viruses (IAVs) [
 <xref ref-type="bibr" rid="CR3">3</xref>]. However, IBVs cause more complications in children, including neurological, muscular [
 <xref ref-type="bibr" rid="CR4">4</xref>] and cardiac-associated events [
 <xref ref-type="bibr" rid="CR5">5</xref>]. Recent studies also showed that the antiviral drug Oseltamivir, the drug most commonly used to treat influenza, was less effective against IBV compared to IAV [
 <xref ref-type="bibr" rid="CR6">6</xref>â€“
 <xref ref-type="bibr" rid="CR8">8</xref>].
</p>
